Compare AMBA & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMBA | HAE |
|---|---|---|
| Founded | 2004 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.7B |
| IPO Year | N/A | 1991 |
| Metric | AMBA | HAE |
|---|---|---|
| Price | $71.37 | $80.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $97.25 | $88.38 |
| AVG Volume (30 Days) | ★ 844.3K | 750.1K |
| Earning Date | 11-25-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.54 |
| EPS | N/A | ★ 3.44 |
| Revenue | $373,850,000.00 | ★ $1,327,850,000.00 |
| Revenue This Year | $39.65 | N/A |
| Revenue Next Year | $9.86 | $6.01 |
| P/E Ratio | ★ N/A | $23.37 |
| Revenue Growth | ★ 48.08 | N/A |
| 52 Week Low | $38.86 | $47.32 |
| 52 Week High | $96.69 | $87.32 |
| Indicator | AMBA | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 58.03 |
| Support Level | $69.62 | $79.20 |
| Resistance Level | $74.58 | $80.94 |
| Average True Range (ATR) | 2.78 | 2.08 |
| MACD | 0.08 | -1.19 |
| Stochastic Oscillator | 18.68 | 17.48 |
Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.